Cochlear : Appendix 3B

Name of entity

COCHLEAR LIMITED

ABN

96 002 618 073

1

+Class of +securities issued or to be issued

Fully paid ordinary shares in Cochlear Limited

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

236

3

Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid

+securities, the amount outstanding

and due dates for payment; if

+convertible securities, the conversion price and dates for conversion)

4

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted

+securities?

If the additional +securities do not rank equally, please state:

• the date from which they do

• the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

• the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Yes

5

Issue price or consideration

$35,980.56

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

Shares granted under the Cochlear Executive Incentive Plan (CEIP).

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

No

6b

The date the security holder resolution under rule 7.1A was passed

N/A

6c

Number of +securities issued without security holder approval under rule 7.1

N/A

6d

Number of +securities issued with security holder approval under rule 7.1A

N/A

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

N/A

6f

Number of +securities issued under an exception in rule 7.2

N/A

6g

If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the

+issue date and both values. Include the source of the VWAP calculation.

N/A

6h

If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

N/A

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

N/A

7

+Issue dates

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

9 October 2017

Number

+Class

8

Number and +class of all

+securities quoted on ASX (including the +securities in section 2 if applicable)

57,539,565

Fully paid ordinary Shares

Number

+Class

228,967

(Note: the balance of options is affected by and may be varied by a number of events, including the lapse of options or options being forfeited)

Options (includes options under CEIP and CELTIP)

37,630

(Note: the balance of performance rights is affected by and may be varied by a number of events, including the lapse of performance rights or performance rights being forfeited)

LTI Performance Rights

72,249

(Note: the balance of performance rights is affected by and may be varied by a number of events, including the lapse of performance rights)

STI Deferral Performance Rights

3,938

(Note: the balance of service rights is affected by and may be varied by a number of events, including the lapse of service rights)

Service Rights